News summary

STEMREGEN® Named to Inc. 5000 for Third Consecutive Year

Source: PR Newswire • Published: 26 Sept 2026, 01:06

Summarized by Masters of Longevity from PR Newswire.

A company growth profile outlining its repeat recognition on a major growth list and what that signals about its market momentum and focus.

STEMREGEN® Named to Inc. 5000 for Third Consecutive Year
Key Takeaways
  • STEMREGEN achieved 1,017% three-year revenue growth, ranking No.
  • The company attributes its sustained expansion to rising interest in regenerative health and longevity products.
  • STEMREGEN's product approach focuses on plant-based supplements intended to increase circulating stem cells and support their function.
Read the full article at PR Newswire ↗

Continue exploring

Recommended MoL Picks

MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickGrowth Hormone Receptor Deletion Extends Mouse LifespanStudy summary: researchers switched off the growth hormone receptor in middle-aged mice and followed survival and physical function.MoL PickFrom Metrics to Better LivingEverstride’s May 2026 Consumer Health Market Briefing shows a wellness market moving from products to systems, from tracking to guidance, and from optimization to meaning. The next winners in longevity may not be the companies that measure the most. They may be the ones that help consumers translate health data into a life they actually want to live.